Our microarray data revealed that STAT1 was up‐regulated in glioma tissues (fold change = 2.193; P < 0.05), whereas a tandem mass spectrum analysis also identified STAT1 as a potential binding partner of RPL36 (Fig. S5A). This evidence concerns the gene RPL36 and central nervous system cancer.